BRIEF published on 11/13/2025 at 15:10, 2 months 5 days ago Reolink Launches Early Black Friday Sale 2025 AI Technology Reolink Sale Early Black Friday Security Cameras Discounted Products
BRIEF published on 11/13/2025 at 15:10, 2 months 5 days ago Reolink lance ses soldes du Black Friday 2025 en avant-première Technologie IA Vente Reolink Vendredi Noir Anticipé Caméras De Sécurité Produits À Prix Réduit
BRIEF published on 11/13/2025 at 15:05, 2 months 5 days ago Jaguar Health Highlights Promising Study Results for Crofelemer in Pediatric Intestinal Failure Crofelemer Microvillus Inclusion Disease Clinical Trial Pediatric Intestinal Failure Parenteral Support
BRIEF published on 11/13/2025 at 15:05, 2 months 5 days ago Jaguar Health met en avant des résultats d'étude prometteurs concernant le crofélémère dans l'insuffisance intestinale pédiatrique Crofelemer Essai Clinique Insuffisance Intestinale Chez L'enfant Maladie À Inclusions Microvillositaires Soutien Parentéral
BRIEF published on 11/13/2025 at 15:05, 2 months 5 days ago Drilling Commences at Bitterroot Resources' Nighthawk Project Mineralization Drilling Nevada Nighthawk Project Gold/Silver
BRIEF published on 11/13/2025 at 15:05, 2 months 5 days ago Début des forages sur le projet Nighthawk de Bitterroot Resources Forage Nevada Mineralisation Projet Nighthawk Or/Argent
BRIEF published on 11/13/2025 at 14:53, 2 months 5 days ago Knaus Tabbert AG Maintains 'Buy' Rating Despite Challenges First Berlin Equity Research BUY Rating Q3 Results Knaus Tabbert AG Chassis Bottleneck
BRIEF published on 11/13/2025 at 14:53, 2 months 5 days ago Knaus Tabbert AG maintient sa recommandation d'achat malgré les difficultés Knaus Tabbert AG Résultats Du Troisième Trimestre Évaluation D'achat Recherche Sur Les Actions De First Berlin Goulot D'étranglement Du Châssis
BRIEF published on 11/13/2025 at 14:50, 2 months 5 days ago Xenetic Biosciences Reports Q3 2025 Financial Results Financial Results Revenue Increase Clinical Trials Pancreatic Carcinoma DNase Technology
BRIEF published on 11/13/2025 at 14:50, 2 months 5 days ago Xenetic Biosciences publie ses résultats financiers du troisième trimestre 2025 Résultats Financiers Essais Cliniques Augmentation Des Revenus Technologie DNase Carcinome Pancréatique
Published on 01/19/2026 at 09:05, 2 hours 4 minutes ago Battery X Metals Announces Closing of $2.4 Million Private Placement Financing with Participation from Former Director and Executive Officer of Fortune 500 Skechers USA, Inc.
Published on 01/19/2026 at 09:05, 2 hours 4 minutes ago BioNxt Reports Successful Final In-Vivo Dosing Study Results Supporting Superior Bioavailability of Cladribine Sublingual ODF
Published on 01/19/2026 at 09:01, 2 hours 8 minutes ago Apex Summarizes Progress to-date and 2026 Outlook at the Rift Rare Earth Project
Published on 01/19/2026 at 08:00, 3 hours 9 minutes ago Core Critical Metals Corp. Applauds Canada Nickel's Milestone Achievements and Highlights Strategic Proximity in Timmins Nickel District
Published on 01/19/2026 at 08:00, 3 hours 9 minutes ago Troubadour Resources Successfully Completes Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/19/2026 at 10:05, 1 hour 4 minutes ago Wrisk welcomes Allianz Holdings plc as a strategic investor as part of its Series B funding round
Published on 01/19/2026 at 10:05, 1 hour 4 minutes ago Corsearch LABS unveils CVAN, rewriting the rules of IP protection
Published on 01/19/2026 at 10:00, 1 hour 9 minutes ago Medios AG enters market for medicinal cannabis
Published on 01/19/2026 at 10:00, 1 hour 9 minutes ago DEBRA Research and the University Medical Center Groningen Launch Dedicated Clinical Trial Site for Epidermolysis Bullosa
Published on 01/19/2026 at 09:45, 1 hour 24 minutes ago ENGIE and Masdar reach financial close on 1.5 GW Khazna Solar PV project in Abu Dhabi
Published on 01/19/2026 at 09:45, 1 hour 24 minutes ago ENGIE et Masdar bouclent le financement du projet solaire Khazna (1,5 GW) à Abou Dhabi
Published on 01/19/2026 at 08:00, 3 hours 9 minutes ago Matthieu Malledant, Veteran CEO and Corporate Advisor, Joins Kerlink Board
Published on 01/19/2026 at 08:00, 3 hours 9 minutes ago Matthieu Mallédant, dirigeant chevronné et conseiller Stratégique, rejoint le Conseil d’Administration de Kerlink
Published on 01/16/2026 at 18:39, 2 days 16 hours ago Nombre total d'actions et droits de vote - décembre 2025
